Searchable abstracts of presentations at key conferences in endocrinology

ea0055p10 | Poster Presentations | SFEEU2018

Multiple bone tumours in primary hyperparathyroidism – not so brown after all

Calvo-Latorre Julia , Lawrence Victor , Arnez Lorena

Case history: A 28 year-old male of British origin was referred with a one-year history of a left-sided chest mass and an abnormal chest X-ray. He was otherwise fit and well, had a past medical history of vitiligo and had no relevant family history. His physical examination revealed some hypopigmented spots on his skin, several tattoos across his back and a firm mass on his left upper chest, which was mildly tender on palpation. He had no other palpable masses.<p class="ab...

ea0055we8 | Workshop E: Disorders of the adrenal gland | SFEEU2018

A pressing diagnosis in an adolescent

O'Toole Sam , Tufton Nicola , Arnez Lorena , Parvanta Laila , Akker Scott

Case history: A 17 year old previously healthy male presented to his local emergency department with a generalised tonic seizure associated with severe hypertension (systolic blood pressure 240 mmHg) and tachycardia. He was intubated and admitted to the Intensive Care Unit. Antimicrobials to cover meningoencephalitis were commenced and his hypertension was managed with intravenous labetalol. He was extubated the following day. He had experienced headaches on a monthly basis fo...

ea0081ep42 | Adrenal and Cardiovascular Endocrinology | ECE2022

Giant non-functioning adrenocortical carcinoma – the elephant in the room

Sim Sing Yang , Bujanova Jana , Hayes Matthew , Tilley Charles , Crabb Simon , Arnez Lorena

Adrenocortical carcinoma (ACC) is a rare malignancy with an incidence of 0.7–2.0 cases/million habitants/year, often with a dismal prognosis. Patients present with abdominal symptoms or symptoms of hormone excess. However, 15% are diagnosed incidentally. (1) A 59y male was referred with progressive lethargy, weight loss, dyspepsia and abdominal distension over the past 2 years. He was dismissive of ‘the elephant in the room’ and in denial. He was pushed to seek ...

ea0032p937 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Carbohydrate metabolism in acromegaly and treatment impact

Biagetti Betina , Valladares Silvia , Arnez Lorena , Dalama Belen , Obiols Gabriel , Mesa Jordi

Introduction: Generously supported by IPSEN)-->Carbohydrate metabolism (CHM) is impaired in over 30% of acromegalic patients. Natural history of acromegaly and treatment modalities, i.e. surgery, somatostatin analogues (SSA) and pegvisomant, may impact in a different way on CHM.Aim: To assess CHM alterations (impaired fasting glucose (IFG) and diabetes mellitus (DM)) in acromegaly and their relationship with cl...